Example: Heart Attack

Search clinical trials for: Pramlintide

Total 54 results

NCT04252612

Recruiting

Biological Outcomes of Pramlintide in Resectable Cutaneous Squamous Cell Carcinoma: A Pilot Study

Conditions: Cutaneous Squamous Cell Carcinoma
NCT04243629

Not yet recruiting

Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 Diabetes

Conditions: Diabetes Mellitus, Type 1; Type 1 Diabetes; Postprandial Hyperglycemia
NCT04163874

Not yet recruiting

Alleviating Carbohydrate Counting for Patients With Type 1 Diabetes Using a Novel Insulin-plus-pramlintide Artificial Pancreas

Conditions: Type 1 Diabetes; Type 1 Diabetes Mellitus; Hyperglycemia, Postprandial
NCT04074317

Completed

Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D

Conditions: Diabetes Mellitus, Type 1; Insulin-dependent Diabetes Mellitus
NCT03993366

Recruiting

Pramlintide and Fiasp Closed-Loop With a Simple Meal Announcement

Conditions: Type 1 Diabetes Mellitus
NCT03981627

Recruiting

A Trial to Assess Safety and Efficacy of ADO09 Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus

Conditions: Type 1 Diabetes Mellitus
NCT03916640

Completed

A Trial to Assess a Co-formulation of an Insulin Analog and Pramlintide in Subjects With Type 1 Diabetes Mellitus

Conditions: Type 1 Diabetes Mellitus
NCT03800875

Recruiting

Triple-hormone (Insulin-pramlintide-glucagon) Closed-loop Strategy to Regulate Glucose Levels Without Carbohydrate Counting

Conditions: Diabetes Mellitus, Type 1
NCT03598075

Completed

Amylin and CGRP Head to Head Provocation in Migraine Without Aura Patients

Conditions: Migraine Without Aura
NCT03560960

Suspended

Multi-Center Development of a Novel Diagnostic Test for Alzheimer's Disease

Conditions: Alzheimer Disease; Mild Cognitive Impairment
NCT03547427

Suspended

Glucagon Counterregulation in Type 1 Diabetes

Conditions: Type 1 Diabetes Mellitus
NCT03512236

Completed

A Trial to Investigate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BioChaperone® Pramlintide Insulin in Patients With Type 1 Diabetes Mellitus

Conditions: Type 1 Diabetes Mellitus
NCT02814123

Completed

Effect of Basal-Bolus Closed-Loop Co-Administration of Insulin and Pramlintide on Improving the Glycemic Control in Type 1 Diabetes

Conditions: Diabetes Mellitus, Type 1
NCT02500979

Completed

Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus

Conditions: Type 1 Diabetes Mellitus
NCT01841359

Unknown status

Pramlintide (Symlin) for the Treatment of Hypoglycemia Following Gastric Bypass Surgery

Conditions: Hypoglycemia; Evidence of Previous Gastric Surgery
NCT01839370

Completed

Phase 2 Study of Adaptive Insulin Meal Supervisor (AIMS) in Adults With Type 1 Diabetes Mellitus

Conditions: Diabetes Mellitus, Type 1
NCT01708044

Completed

Effect of Different Fixed Pramlintide:Insulin Dose Ratios on Postprandial Glucose in T1DM

Conditions: Type 1 Diabetes
NCT01434862

Terminated

Pramlintide Combined With Model Predictive Control Algorithm

Conditions: Type 1 Diabetes Mellitus
NCT01269008

Completed

Closed Loop System With Pramlintide Versus Exenatide

Conditions: Type 1 Diabetes
NCT01269047

Completed

Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia

Conditions: Type 1 Diabetes
NCT01235741

Terminated

A Study To Examine The Efficacy And Safety Of Pramlintide+Metreleptin In Obese Subjects

Conditions: Obesity
NCT01165944

Withdrawn

Effectiveness Study of Pramlintide to Treat Post-Transplant Diabetes Mellitus

Conditions: Diabetes Mellitus
NCT01137695

Unknown status

Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus

Conditions: Type 2 Diabetes Mellitus
NCT00950677

Completed

The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes

Conditions: Type 2 Diabetes
NCT00842075

Completed

Pramlintide in Adolescents With Type 1 Diabetes

Conditions: Type 1 Diabetes
NCT00819234

Completed

Extension Study of Protocol DFA102 to Examine the Long-Term Safety, Tolerability, and Effect on Body Weight of Pramlintide Administered in Combination With Metreleptin

Conditions: Obesity
NCT00790699

Terminated

Safety Study of Using Symlin Alongside Insulin in a Multiple Injection Port

Conditions: Type 1 Diabetes; Type 2 Diabetes
NCT00732147

Withdrawn

Effects of Pramlintide on Endogenous Production of Very-low-density-lipoprotein (VLDL)-Triglyceride and Glucose in the Post Prandial State in T2DM

Conditions: Type 2 Diabetes
NCT00691158

Active, not recruiting

A Study of the Functional Magnetic Resonance Imaging Response to Leptin and Pramlintide

Conditions: Obesity
NCT00690235

Completed

Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia

Conditions: Schizophrenia; Schizoaffective Disorder; Diabetes; Weight Gain
NCT00673387

Completed

Study to Examine Safety, Tolerability, and Effect on Body Weight of Metreleptin Administered in Conjunction With Pramlintide in Obese and Overweight Subjects

Conditions: Overweight; Obesity
NCT00505882

Withdrawn

Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes

Conditions: Type 1 Diabetes
NCT00502138

Completed

A Pilot Study of Continuous Subcutaneous Pramlintide Infusion Therapy in Patients With Type 1 Diabetes

Conditions: IDDM
NCT00489645

Completed

Effect of Hyperglycemia on Gastric Emptying Interactions With Pramlintide

Conditions: Type 1 Diabetes
NCT00467649

Completed

A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes

Conditions: Type 2 Diabetes Mellitus
NCT00460304

Completed

The Effect of Pramlintide on Meal Time Insulin Bolus

Conditions: Type 1 Diabetes
NCT00444561

Completed

Exploratory Study to Evaluate Various Pharmacodynamic Effects of Subcutaneously Infused or Injected Pramlintide in Obese Subjects

Conditions: Overweight; Obesity
NCT00442767

Completed

Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes Mellitus

Conditions: Type 1 Diabetes Mellitus
NCT00402077

Completed

A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects

Conditions: Overweight; Obesity
NCT00392925

Completed

A Study to Evaluate the Effect on Body Weight of Leptin Administered in Conjunction With Pramlintide in Overweight and Obese Subjects

Conditions: Overweight; Obesity
NCT00313183

Completed

A Study to Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes Mellitus

Conditions: Type 1 Diabetes Mellitus
NCT00291772

Completed

Continuous Subcutaneous Infusion of Pramlintide and Insulin

Conditions: Type 1 Diabetes
NCT00240253

Completed

A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 Diabetes

Conditions: Type 2 Diabetes Mellitus
NCT00229658

Completed

An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes

Conditions: Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus
NCT00206258

Completed

The Role of Amylin and Glucagon in T1DM

Conditions: Type 1 Diabetes
NCT00206297

Completed

The Effect of Prolonged Pramlintide Infusion in Pediatric Diabetes

Conditions: Type 1 Diabetes
NCT00189514

Completed

A Study to Examine the Long Term Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects

Conditions: Obesity
NCT00112021

Completed

A Study to Examine the Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects

Conditions: Obesity
NCT00108004

Completed

Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus

Conditions: Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus
NCT00107107

Completed

Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus

Conditions: Diabetes Mellitus, Type 1

Search clinical trials for: Pramlintide

Recent CRA jobs

Assoc Scientist- ICD

Associate Validation Analyst II

Project & Budget Coordinator/Analyst

Clinical Trial Coordinator - C (Italian/German/Spanish/French is advantage)

Senior Nurse Practitioner ; AES

Sr Project Manager - Vaccines Team (US Homebased)

Assoc Clinical Research Coord; AES

Medical Information Associate

QA Auditor I or QA Auditor II

Associate Marketing Manager / Marketing Manager